noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Sotera Health Co.

Management Change/Compensation (Form 8-K)
Columbus McKinnon Corporation

From montratec to CMCO: Many Benefits—What’s Changing and What’s[...]
Neumora Therapeutics Inc

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and[...]

Healthcare

Gemeinsamer Bundesausschuss

08/11/2026 | Press release | Archived content

Arzneimittel-Richtlinie/Anlage II: Einleitung eines Stellungnahmeverfahrens – TrenibotulinumtoxinE

Beschluss

Arzneimittel-Richtlinie/Anlage II:
Einleitung eines Stellungnahmeverfahrens - TrenibotulinumtoxinE

Beschlussdatum: 11.08.2026

Inkrafttreten: mit Beschlussdatum

Richtlinie

Arzneimittel-Richtlinie

Richtlinien-Anlage

Anlage II: Lifestyle Arzneimittel

Zuständiger Unterausschuss

Arzneimittel

Gemeinsamer Bundesausschuss published this content on August 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 13, 2026 at 08:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format